Prevalence of Hepatitis B Surface Antigen and Associated Risk Factors with Hepatitis B Infection among Pregnant Women in Northeast of Iran

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 167

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JIML-5-3_008

تاریخ نمایه سازی: 7 اسفند 1401

Abstract:

Background and Aims: Almost ۳۵۰ million people worldwide are carriers of hepatitis B virus. The rate of chronic carriers in Iran is about ۳%.  Therefore Iran is categorized as a country with moderate rate of infection with this virus. In developing countries, transmission from mother to fetus and newborn is considered as one of the main routes of transmission. So, this study investigated the prevalence of hepatitis B and its risk factors in pregnant women. Material and Methods: In this descriptive cross-sectional study which has been done in ۲۰۱۰-۲۰۱۱, of ۷۵۹ pregnant women referred to the Central Laboratory of ACCER and laboratory of Mashhad Ghaem hospital for HBsAg testing, after obtaining consent form, patients entered to the study with simple non-probability sampling, and a questionnaire was completed about demographic characteristics and related factors. Then data were analyzed by SPSS ver.۱۳. Results: The mean age of participants was ۲۸.۱۶ ± ۴.۸, the prevalence of HBsAg among pregnant women was reported ۰.۳%, and also because of finding only two cases of HBsAg positive, significant association was not found with socio-demographic factors such as; vaccination history of hepatitis B (P= ۰.۵۲۷) and risk factors including family history of hepatitis B or hepatitis C (P= ۰.۹۹۹). Conclusions: Our study revealed that the prevalence rate of HBsAg positive among pregnant women is low. The prevalence of obtained HBsAg in this study compared to other studies from Iran is low, so, further studies with more cases are necessary to achieve real estimation of HBsAg positive among pregnant women.

Authors

Seyed Javad Pourafzali

Research Center for HIV/AIDS, HTLV and Viral Hepatitis, Iranian Academic Center for Education, Culture and Research (ACECR), Mashhad, Iran.

Azad Khaledi

۲ Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, IR Iran. ۳ Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.

Rahele Miri

۴ Department of Parasitology and Mycology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed Ali Akbar Shamsian

۵ Department of Immunology, Immunology Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed Abdolrahim Rezaee

۶ Autoimmune Diseases Research Center, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.

Ahmad Piroozmand

۷ Antimicrobial Resistance Research Center, Department of Virology and Microbiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Kiarash Ghazvini

۷ Antimicrobial Resistance Research Center, Department of Virology and Microbiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • . Kheiri L, Makvandi S. The prevalence of Hepatitis B ...
  • . Stewart BW, Wild CP. World cancer report ۲۰۱۴. Lyon: ...
  • . Duvnjak M, Virović-Jukić L, Gomerčić-Palčić M, Stojsavljević S. Classification ...
  • . Abdolahi N, Keshtkar A, Semnani S, Roshandel G, Beshrat ...
  • . Shepard CW, Simard EP, Finelli L, Fiore AE, Bell ...
  • . Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology ...
  • . Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatol. ...
  • . Liu M, Cai H, Yi W. Safety of telbivudine ...
  • . Choisy M, Keomalaphet S, Xaydalasouk K, Quet F, Latthaphasavang ...
  • . Cunningham F, Leveno K, Bloom S, Hauth J, Rouse ...
  • . Sherlock S, Dooley J. Diseases of the liver and ...
  • . Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, ...
  • . Ziol M, Handra‐Luca A, Kettaneh A, Christidis C, Mal ...
  • . Abubakar II, Tillmann T, Banerjee A. Global, regional, and ...
  • . Centers for Disease Control and Prevention. Surveillance for viral ...
  • . Buster EH, Hansen BE, Lau GK, Piratvisuth T, Zeuzem ...
  • . Forouzanfar M, Mohammad K, Majdzadeh R, Malekzadeh R, Abolhasani ...
  • . Alavian SM. Ministry of Health in Iran is serious ...
  • . Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima ...
  • . Mir Ghafoor Vand MS, Rafiee A. Prevalence of Hepatitis ...
  • . Cheraghali YS, Behnam N, Azarhoosh R. The prevalence of ...
  • . Sharifi KF, Sanee Moghadam E, Salehi M, Alavi R, ...
  • . Khalil MKM, Al-Mazrou YY, Al-Jeffri M, Al-Ghamdi YS, Mishkhas ...
  • . Kumar A, Sharma KA, Gupta R, Kar P, Chakravarti ...
  • . Hadinedoushan H, Dehghan-Manshadi M, Zare F. Determination of hepatitis ...
  • نمایش کامل مراجع